OVARIAN SEROUS TUMOR
Clinical trials for OVARIAN SEROUS TUMOR explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SEROUS TUMOR trials appear
Sign up with your email to follow new studies for OVARIAN SEROUS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat ovarian cancer: drug combo shows promise in clinical trial
Disease control OngoingThis study tests whether adding an experimental drug called M6620 to standard chemotherapy (gemcitabine) works better than gemcitabine alone for people with ovarian, peritoneal, or fallopian tube cancer that has returned and no longer responds to platinum-based treatments. About …
Matched conditions: OVARIAN SEROUS TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug combo could offer alternative to chemo for recurrent ovarian cancer
Disease control OngoingThis phase 3 study tested whether the targeted drugs olaparib (alone or combined with cediranib) work better than standard platinum-based chemotherapy for women with ovarian, fallopian tube, or primary peritoneal cancer that came back after initial treatment. About 579 women with…
Matched conditions: OVARIAN SEROUS TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC